OPGN

OPGN Stock Price Increases Over 20% Pre-Market: Why It Happened

OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed

OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars

OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland

OpGen, Inc. (OPGN) CEO Oliver Schacht on Q1 2021 Results - Earnings Call Transcript

OpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue Estimates

Recap: OpGen Q1 Earnings